null Option on FibroGen
| FGEN Stock | USD 7.71 0.15 1.98% |
FibroGen's latest option contracts expiring on September 19th 2025 are carrying combined implied volatility of 1.2 with a put-to-call open interest ratio of 0.01 over 12 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on September 19th 2025.
Open Interest Against September 19th 2025 Option Contracts
2025-09-19
The chart above shows FibroGen's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. FibroGen's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for FibroGen's option, there is no secondary market available for investors to trade.
In The Money vs. Out of Money Option Contracts on FibroGen
Analyzing FibroGen's in-the-money options over time can help investors to take a profitable long position in FibroGen regardless of its overall volatility. This is especially true when FibroGen's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money FibroGen's options could be used as guardians of the underlying stock as they move almost dollar for dollar with FibroGen's stock while costing only a fraction of its price.
Please note that buying 'in-the-money' options on FibroGen lessens the impact of time decay, as they carry both intrinsic and time value. So, even if FibroGen's value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money FibroGen contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if FibroGen Stock moves the wrong way.
FibroGen Current Options Market Mood
FibroGen's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps FibroGen Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most FibroGen's options investors are not very successful. FibroGen's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current FibroGen contract
Base on the Rule 16, the options market is currently suggesting that FibroGen will have an average daily up or down price movement of about 0.075% per day over the life of the 2025-09-19 option contract. With FibroGen trading at USD 7.71, that is roughly USD 0.005782. If you think that the market is fully incorporating FibroGen's daily price movement you should consider buying FibroGen options at the current volatility level of 1.2%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Purchasing FibroGen options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" FibroGen calls. Remember, the seller must deliver FibroGen stock to the call owner when a call is exercised.
FibroGen Option Chain
When FibroGen's strike price is surpassing the current stock price, the option contract against FibroGen stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
FibroGen's option chain is a display of a range of information that helps investors for ways to trade options on FibroGen. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for FibroGen. It also shows strike prices and maturity days for a FibroGen against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | FGEN250919C00007500 | 4 | 7.5 | 0.0 - 4.7 | 4.7 | Out |
Call | FGEN250919C00005000 | 0 | 5.0 | 0.0 - 0.95 | 0.95 | |
Call | FGEN250919C00002500 | 300 | 2.5 | 0.0 - 0.25 | 0.25 | Out |
Call | FGEN250919C00001500 | 114 | 1.5 | 0.0 - 2.45 | 2.45 | Out |
Call | FGEN250919C00001000 | 15 | 1.0 | 0.0 - 4.7 | 4.7 | Out |
Call | FGEN250919C00000500 | 1876 | 0.5 | 0.0 - 0.05 | 0.04 | Out |
Put | FGEN250919P00007500 | 0 | 7.5 | 4.2 - 7.5 | 4.2 | In |
Put | FGEN250919P00005000 | 0 | 5.0 | 1.7 - 5.0 | 1.7 | In |
Put | FGEN250919P00002500 | 0 | 2.5 | 0.0 - 2.5 | 2.5 | In |
Put | FGEN250919P00001500 | 0 | 1.5 | 0.0 - 1.5 | 1.5 | In |
Put | FGEN250919P00001000 | 20 | 1.0 | 0.0 - 0.9 | 0.9 | In |
Put | FGEN250919P00000500 | 1 | 0.5 | 0.0 - 0.35 | 0.25 | In |
FibroGen Total Stockholder Equity
Total Stockholder Equity |
|
FibroGen Corporate Management
| Kirk MBA | Chief Officer | Profile | |
| Rahul Kaushik | Technical Development | Profile | |
| Mr JD | Chief Officer | Profile | |
| Enrique Conterno | CEO Director | Profile | |
| Barry Berkowitz | Founder | Profile | |
| Christine Chung | Senior Operations | Profile | |
| David DeLucia | Vice Relations | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in FibroGen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in FibroGen Stock, please use our How to Invest in FibroGen guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of FibroGen. If investors know FibroGen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about FibroGen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.536 | Earnings Share (30.00) | Revenue Per Share | Quarterly Revenue Growth (0.89) | Return On Assets |
The market value of FibroGen is measured differently than its book value, which is the value of FibroGen that is recorded on the company's balance sheet. Investors also form their own opinion of FibroGen's value that differs from its market value or its book value, called intrinsic value, which is FibroGen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because FibroGen's market value can be influenced by many factors that don't directly affect FibroGen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between FibroGen's value and its price as these two are different measures arrived at by different means. Investors typically determine if FibroGen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, FibroGen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.